Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats.
Thyrotoxicosis is known to induce a broad range of changes in carbohydrate metabolism. Recent studies have identified the sympathetic and parasympathetic nervous system as major regulators of hepatic glucose metabolism. The present study aimed to investigate the pathogenesis of altered endogenous glucose production (EGP) in rats with mild thyrotoxicosis. Rats were treated with methimazole in drinking water and l-thyroxine (T(4)) from osmotic minipumps to either reinstate euthyroidism or induce thyrotoxicosis. Euthyroid and thyrotoxic rats underwent either a sham operation, a selective hepatic sympathetic denervation (Sx), or a parasympathetic denervation (Px). After 10 days of T(4) administration, all animals were submitted to a hyperinsulinemic euglycemic clamp combined with stable isotope dilution to measure EGP. Plasma triiodothyronine (T(3)) showed a fourfold increase in thyrotoxic compared with euthyroid animals. EGP was increased by 45% in thyrotoxic compared with euthyroid rats and correlated significantly with plasma T(3). In thyrotoxic rats, hepatic PEPCK mRNA expression was increased 3.5-fold. Relative suppression of EGP during hyperinsulinemia was 34% less in thyrotoxic than in euthyroid rats, indicating hepatic insulin resistance. During thyrotoxicosis, Sx attenuated the increase in EGP, whereas Px resulted in increased plasma insulin with unaltered EGP compared with intact animals, compatible with a further decrease in hepatic insulin sensitivity. We conclude that chronic, mild thyrotoxicosis in rats increases EGP, whereas it decreases hepatic insulin sensitivity. Sympathetic hepatic innervation contributes only to a limited extent to increased EGP during thyrotoxicosis, whereas parasympathetic hepatic innervation may function to restrain EGP in this condition.
Klieverik
Lars P
LP
Academic Medical Center, Univ. of Amsterdam, Dept. of Endocrinology and Metabolism, F5-162, 1105 AZ Amsterdam, The Netherlands. L.P.Klieverik@amc.nl
Sauerwein
Hans P
HP
Ackermans
Mariëtte T
MT
Boelen
Anita
A
Kalsbeek
Andries
A
Fliers
Eric
E
D000818:Animals; D017763:Autonomic Denervation; D001786:Blood Glucose / Q000032:analysis; D005947:Glucose / Q000096:biosynthesis*; D015309:Glucose Clamp Technique; D006946:Hyperinsulinism; D007328:Insulin / Q000097:blood; D007700:Kinetics; D008099:Liver / Q000201:enzymology / Q000294:innervation* / Q000378:metabolism*; D008297:Male; D008713:Methimazole / Q000008:administration & dosage; D017764:Parasympathectomy; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D013562:Sympathectomy; D013963:Thyroid Hormones / Q000097:blood; D013971:Thyrotoxicosis / Q000139:chemically induced / Q000378:metabolism*; D013974:Thyroxine / Q000008:administration & dosage
D001786:Blood Glucose; D007328:Insulin; D012333:RNA, Messenger; D013963:Thyroid Hormones; D008713:Methimazole; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D005947:Glucose; D013974:Thyroxine